Suzhou Shengdi Pharmaceutical

Suzhou Shengdi Pharmaceutical is a major subsidiary of Jiangsu Hengrui Pharmaceuticals, one of China's leading innovative pharmaceutical companies. Based in the Suzhou Industrial Park, the company serves as a core hub for the research, development, and large-scale manufacturing of high-end innovative drugs. Its portfolio spans multiple therapeutic areas, with a primary focus on oncology, metabolic diseases, and autoimmune disorders. Suzhou Shengdi operates state-of-the-art facilities that comply with international GMP standards, supporting the global clinical development of Hengrui's pipeline, including small molecules, monoclonal antibodies, and antibody-drug conjugates. The company plays a pivotal role in transitioning its parent company from a generic-focused manufacturer to a global innovation-driven biopharmaceutical leader.